The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bayer
Six-year safety and efficacy results from the CHRONOS-1 study of the PI3K inhibitor copanlisib in patients with relapsed or refractory follicular lymphoma.
 
Martin H. Dreyling
Consulting or Advisory Role - Abbvie/Genentech (Inst); Acerta Pharma/AstraZeneca; Amgen; Bayer/Vital; Beigene; Celgene/Jazz; Genmab; Gilead Sciences; Incyte; Janssen-Cilag; Lilly Medical; morphosys; Novartis; Roche
Speakers' Bureau - Amgen; Bayer Health; Beigene; Celgene; Gilead Sciences; Janssen-Cilag; Roche Pharma AG
Research Funding - Abbvie (Inst); Bayer (Inst); Celgene (Inst); Janssen-Cilag (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Celgene; Janssen-Cilag; Roche Pharma AG
 
Armando Santoro
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; Incyte; MSD; Pfizer; Sanofi; SERVIER
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; Bayer; BMS; Celgene; Eisai; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Sandoz; Servier; Takeda
 
Sirpa Leppä
Honoraria - Gilead Sciences; Novartis
Consulting or Advisory Role - Genmab; Gilead Sciences; Incyte; Novartis; Orion; Roche
Research Funding - Bayer; Celgene; Genmab; HUTCHMED; Nordic Nanovector; Novartis; Roche
 
Judit Demeter
No Relationships to Disclose
 
George Follows
Honoraria - Abbvie; AstraZeneca; Janssen Oncology; Lilly
Consulting or Advisory Role - Janpix Limited/Centessa Pharmaceuticals
Speakers' Bureau - Takeda
Travel, Accommodations, Expenses - Janssen Oncology; Takeda
 
Georg Lenz
Honoraria - Abbvie; ADC Therapeutics; AstraZeneca; Bristol-Myers Squibb; Constellation Pharmaceuticals; Genmab/Seattle Genetics; Gilead Sciences; Incyte; Janssen-Cilag; Novartis; Roche/Genentech; SOBI
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; Bristol-Myers Squibb; Genase Therapeutics; Genmab/Seattle Genetics; Gilead Sciences; Hexal; Immagene; Incyte; Janssen-Cilag; Karyopharm Therapeutics; Lilly; Miltenyi Biomedicine; MorphoSys; Novartis; PentixaPharm; Roche/Genentech; Sobi
Research Funding - AGIOS; Aquinox; AstraZeneca; Bayer; Gilead Sciences; Janssen-Cilag; MorphoSys; Roche/Genentech; Verastem
Expert Testimony - Roche
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; Janssen-Cilag; Roche/Genentech
 
Won Seog Kim
No Relationships to Disclose
 
Luigina Mollica
No Relationships to Disclose
 
Arnon Nagler
No Relationships to Disclose
 
Colin Phipps Diong
No Relationships to Disclose
 
Mariano Provencio
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; F. Hoffmann LaRoche; Janssen; Laboratorio Brasiliense; Lilly O.
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb; Pierre Fabre; Roche; Takeda
Patents, Royalties, Other Intellectual Property - P201731067. Prognosis methods for patients with folicularlymphoma. España. 16/05/2017. FIBHUPH; PCT/ES2018/070463
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly O.; Pierre Fabre; Roche
 
Massimo Magagnoli
No Relationships to Disclose
 
Atanas Radinoff
Honoraria - Abbvie; Novartis; Pfizer; Roche; SOBI; Swixx BioPharma
Consulting or Advisory Role - Roche; SOBI; Swixx BioPharma
Travel, Accommodations, Expenses - Roche
 
Javier Munoz
Honoraria - Curio/Vaniam Group; Kyowa Kirin; OncView; Physicans' Education Resource; Seagen; Targeted Oncology
Consulting or Advisory Role - Abbvie/Pharmacyclics; ADC Therapeutics; Alexion Pharmaceuticals; Bayer; BeiGene; Bristol-Myers Squibb; Debiopharm Group; Epizyme; Fosun Kite; Genmab; Innovent Biologics; Janssen; Juno/Celgene; Karyopharm Therapeutics; Kite, a Gilead Company; Kyowa Kirin; Loxo/Lilly; MEI Pharma; MorphoSys/Incyte; Novartis; Pfizer; Seagen; Secura Bio; Servier; TG Therapeutics
Speakers' Bureau - Acrotech/Aurobindo; AstraZeneca; Bayer; BeiGene; Celgene/Bristol-Myers Squibb; Genentech/Roche; Kite, a Gilead Company; Kyowa Kirin; Pharmacyclics/Janssen; Seagen; Verastem
Research Funding - Bayer; Celgene; Genentech; Incyte; Janssen; Kite, a Gilead Company; Merck; Millennium; Pharmacyclics; Portola Pharmaceuticals; Seagen
 
Anjun Cao
Employment - Bayer
 
Florian Hiemeyer
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Fatuma Odongo
Employment - Bayer
 
Jose E. Garcia-Vargas
Employment - Bayer
 
Barrett H. Childs
No Relationships to Disclose
 
Pier Luigi Zinzani
Consulting or Advisory Role - ADC Therapeutics; BeiGene; Bristol-Myers Squibb; Celltrion; EUSA Pharma; Gilead Sciences; Incyte; Janssen-Cilag; Kyowa Hakko Kirin; MSD; Novartis; Roche; Sandoz; Secura BIO; SERVIER; Takeda; TG Therapeutics
Speakers' Bureau - EUSA Pharma; MSD; Novartis